Time to start!
Explore the transformative power of RWE in real-world healthcare settings. Watch the replays and be part of the global conversation!
Did you miss the Health Data Forum Global Hybrid Summit 2024 in Cascais, Portugal? Here’s your chance to catch up on the most impactful moments!
We’re thrilled to announce a series of exclusive social media live events where we will be retransmitting the keynote sessions and discussions that shaped the future of health data innovation.
Shaping the Future of Health Data
Join us for an exclusive series of social media live events featuring the retransmission of keynotes and discussions from our landmark summit held in Cascais, Portugal.
Whether you missed it or want to revisit the insights, this is your chance to engage with the groundbreaking conversations that are shaping the future of health data.
Following the success of our last session, we’re excited to bring you another insightful discussion on Best Practices in RWE Data Governance, Analysis, and Security. Moderated by Hugo Pedrosa (IQVIA Portugal), this session features expert insights from Pantelis Natsiavas (eHealth Lab, Centre for Research and Technology Hellas), Niels Bolding (Health-RI Netherlands), and Paola Quatronni (EACTS – European Association for Cardio-Thoracic Surgery). Dive into key topics such as data governance challenges, centralized vs. federated models, security considerations under EHDS, and the role of AI in RWE analytics.
Stay tuned for the live replay on LinkedIn, YouTube, and Meta via the Health Data Forum!
Stay Connected! Follow our YouTube Channel for exclusive access to keynotes, discussions, and insights shaping the future of healthcare innovation. Subscribe now and never miss an update!
Replay Summary: The Burden of Disease in Real-World Settings
The Health Data Forum Global Hybrid Summit 2024 will rebroadcast one of its most insightful sessions: "The Burden of Disease in Real-World Settings." This session brings together leading experts to explore how real-world data is transforming our understanding of disease impact, public health strategies, and patient outcomes.
Key Discussions
Panelists
Chair: Gustavo Tato Borges – President, Portuguese Public Health Medical Association
Speakers:
Moderator: Mariana Canelas Pais, MTG Research & Development Lab
Tune in live on LinkedIn and register here to watch on March 25 (14:00 GMT) to catch this replay and gain valuable insights into how real-world evidence is shaping the future of disease management and public health. Don't miss it!
Our distinguished keynote speakers at the Health Data Forum Global Hybrid Summit 2024 delved into the multifaceted role of Real-World Evidence (RWE) in transforming healthcare. From groundbreaking innovations to shaping public policy and regulatory frameworks, their diverse expertise shed light on new possibilities for harnessing health data to drive meaningful change and improve outcomes >> More here.
The Health Data Forum is a platform dedicated to advancing healthcare through the effective use of health data. Established in 2020, it aims to foster thought leadership and innovation by bringing together data scientists, healthcare professionals, patients, and policymakers to address the complexities of health data utilization.
A cornerstone of the Forum's initiatives is the annual Health Data Forum Global Hybrid Summit. This event serves as a convergence point for global leaders and innovators to explore the transformative potential of Real-World Evidence (RWE) in healthcare. The 2024 summit, themed "RWE for the Real World," was held from November 14th to 16th at the NOVA Medical School in Cascais, Portugal. It featured plenary sessions, workshops, and networking opportunities, focusing on practical applications of RWE to enhance patient care, accelerate research, and drive innovation.
The Forum's mission is to create a collaborative ecosystem where diverse perspectives can converge to shape the future of healthcare systems. By organizing events and facilitating discussions, the Health Data Forum aims to address challenges in health data governance, analysis, and security, ultimately contributing to smarter healthcare and more efficient research.
Ready to connect with the brightest minds in healthcare data? This year, we’re bringing the Health Data Forum Global Hybrid Summit to Wales, where we will explore the practical applications and future of Real-World Evidence (RWE) in healthcare. Whether you’re attending in person or virtually, this summit is your opportunity to engage with industry leaders, exchange insights, and shape the future of healthcare innovation.
This year, we take the Health Data Forum Global Hybrid Summit to a new and exciting location—Wales! Set against a backdrop of innovation and rich healthcare research ecosystems, the summit provides a unique space for health data scientists, digital health specialists, and industry leaders to discuss the latest trends, innovations, and challenges in health data governance, AI, and RWE-driven healthcare transformation.
From our early events in Porto to our impactful partnership in Ghent, and the incredible success of last year’s Health Data Forum Global Hybrid Summit in Cascais, we have consistently elevated the conversation around health data.
In September 2025, we are bringing the Health Data Forum Global Hybrid Summit to Wales, where global experts will converge to foster collaboration, share best practices, and drive actionable strategies for the future of health data. Building on the momentum of Cascais 2024, this year’s summit will further advance discussions on Real-World Evidence, digital health innovation, and health data governance in a dynamic and engaging setting.
We are also exploring additional opportunities in 2025 to continue expanding this important dialogue—stay tuned for more updates!
Big things are coming—be part of the movement!
In 2025, the Health Data Forum Global Hybrid Summit is expanding its reach! Join us in Wales this September for an in-depth exploration of Real-World Evidence (RWE), health data governance, and digital health transformation. Plus, stay tuned as we explore a potential edition in Dubai, further broadening the conversation on global health data innovation.
By engaging in multiple Health Data Forum events, you’ll have the opportunity to deepen your knowledge, connect with world-class experts, and contribute to shaping the future of healthcare.
Hear from leading global speakers and thought leaders in health data science, AI in healthcare, and digital health innovation.
🔍 Discover the latest cutting-edge technologies and methodologies driving the future of data-driven healthcare.
Connect with peers, industry leaders, and innovators in an intimate setting designed to foster collaboration and meaningful exchange.
Engage in panels and workshops that dive deep into:
✔️
Real-World Evidence (RWE) and its role in transforming healthcare
✔️
AI-driven innovations in health data utilization
✔️
Strategies to improve health access and equity worldwide
With multiple opportunities to participate in 2025, the Health Data Forum is bringing together the brightest minds to accelerate innovation in healthcare.
Be part of the movement!
Hear from world-leading speakers and thought leaders in health data science and digital health. Discover the latest technologies and methodologies shaping the future of healthcare, with a special focus on RWE and its impact on clinical practice and healthcare policy.
Connect with peers, industry leaders, and innovators in an intimate setting that fosters collaboration and exchange. Participate in panels and workshops that explore the practical use of Real-World Evidence, AI in healthcare, and strategies to address health access inequities.
Speakers directory
Our lineup of distinguished speakers will bring a wealth of knowledge and experience to the summit, driving meaningful discussions and fostering innovation in health data. Their insights will be instrumental in shaping the future of healthcare and enhancing our collective understanding of Real-World Evidence.
Operational Manager ad interim Central Biobank Charité (ZeBanC)
Madeira Regional Director for Integrated Public Policies and Longevity
President of the Portuguese Association of Inflammatory Bowel Disease, Ulcerative Colitis and Crohn's Disease
Municipal Director for Health and Social Affairs at Cascais City Council
Regional Director of Health at the Regional Secretariat of Health and Civil Protection of the Government of Madeira.
Cascais Executive Councillor for Health, Social Affairs and Human Rights
Mayor of Cascais
Manager Public Policy, Affairs & Communication at Health-RI
Senior Scientific Officer, Health Research Programmes at DG-RTD European Commission
Head of Care Journeys at UpHill Health
Vice-Dean Nova Medical School
European Medicines Agency Senior Advisor and Wellcome Trust Clinical Research Fellow at University of Dundee
Head of Alliance (UK Health Data Research Alliance) & Public Involvement and Engagement (HDR UK)
SRF at University of Crete, Vice President of HTA section at EUPHA, Co-Chair of the RWE and Artificial Intelligence Interest Group at HTAi.
CEO at Ribera Salud
CEO & Co-founder at UpHill Health
Senior Health Economist at OECD
CEO at Dr. Soliman Fakeeh Hospital Jeddah
Researcher at Nova SBE Health Economics & Management
Head of Market Access and Public Affairs at Sanofi, Guest Professor Faculty of Medicine University of Porto
Professor in Registry Epidemiology at Sahlgrenska Academy at Gothenburg University
Internal Medicine Hospital Resident at Entre Douro e Vouga Health Authority
Public Health Medical Specialist, President of the National Association of Public Health Doctors (ANMSP)
Dean Nova Medical School
Country Lead, Sanofi Portugal
Hugo Pedrosa, Principal, RWE Consulting, IQVIA
Head of Intelligent Systems at Fraunhofer Portugal
Municipal Chief Digital Officer City of Cascais
Professor and Senior Consultant, Department of Surgery, Zealand University Hospital and University of Copenhagen
Technical and Scientific Manager at Health Solutions and Evidence Division, National Association of Pharmacies
Group Leader at Cancer Nanomedicine Lab, Co-founder at TargTex and Vice-Dean Nova Medical School
Research and Patient Engagement Director at Cancer Patients Europe - CPE
Pediatrician and Board Member at Shwachman Syndrome Support Holland and Foundation Rare Care World
Chief Transformation Officer at Ribera Salud Group
Former Health Care Minister
Executive Director at EUPATI
Executive Director at Patient Innovation
Data Protection Officer
Data Science Director, MTG Research & Development Lab
CTO at Sigil Scientific Enterprises
Technical Lead at Health-RI
Head of eHealth Lab at Institute of Applied Biosciences, Centre for Research and Technology Hellas
Director of Quality Improvement at EACTS - European Association for Cardio-Thoracic Surgery
AKA Paul Nunesdea, PhD, CPF, Health Data Forum Firestarter
President of the Boad at Vale do Ave Local Health Authority
Regional Secretary of Health and Civil Protection, Madeira Regional Government
CCIO Wales. Medical Director at Digital Health and Care Wales
President of INFARMED, I.P., National Authority of Medicines and Healthcare Products
Head of Transformation and Strategic Partnerships - Nova Medical School;
Director Technology Innovation Support Center at Aga Khan University
Founder & Director at Avenzoar Consulting
Associate Professor at Harvard Medical School
Founder & CEO Sigil Scientific Enterprises
Our esteemed Scientific Board and Honorary Members guide the Health Data Forum Global Hybrid Summit with their expertise and dedication. They ensure our events meet the highest standards in health data science, fostering global collaboration and innovation in healthcare.
Dean, Faculty of Medicine
University of Porto
President of the Order of Physiotherapists
Founder & CEO Virtual Nursing Academy, Assistant Professor, School of Nursing, University of Calgary, Executive Chair of the Advisory Board Digital Health Portugal
Chief Physician of Portugal
President of the ANF - National Association of Pharmacies
President of the Order Psychologists
Executive Chair Advisory Board Health Data Forum, Assistant Professor of Medicine Westchester Medical Cente
Dean of the Order of Pharmacists
Head, Computational & Cognitive Health and Medicine-CMD at NEOM
Dean at NOVA Medical School
Associate Professor at ISCTE - Instituto Universitário de Lisboa and Professor at Universidade da Beira Interior
Dean of the Nursing Order
Chair-person at ZIMAM, Public Health specialist at Dubai Health Authority
Chief Executive Officer (CEO) at iBET – Instituto de Biologia Experimental e Tecnológica
Full Professor at Faculdade Ciências Médicas and Vice President of Agency for Clinical Research and Biomedical Innovation
Head of Data Analytics and Methods Task Force at European Medicines Agency
Dean Nova School of Public Health
Director-General of Health
Chair Emeritus - Centre for Health, Innovation, Policy & Digital Health and President Health Parliament India
Professor of Health Informatics at Faculty of Medicine Porto University & Co-Founder Opvance
, President of the Regional Coordination and Development Commission of Lisbon and Tagus Valley (CCDR LVT)
Our diverse lineup of keynote speakers at the Health Data Forum Global Hybrid Summit 2024 will explore Real-World Evidence (RWE) from various angles—ranging from innovative healthcare approaches to public policy and regulatory decision-making. Each speaker brings unique expertise that will shape the future of healthcare by leveraging health data for meaningful impact.
Dr Shirley Wang
is a distinguished Associate Professor at Harvard Medical School, specializing in pharmacoepidemiology and health data science. She holds a Ph.D. in Epidemiology from Harvard University and is renowned for her work on real-world evidence (RWE) and its application in healthcare. Dr. Wang is a co-founder of the REPEAT Initiative, which aims to improve the reproducibility and transparency of RWE studies. She has authored numerous influential publications and has been recognized with prestigious awards, including the Leon I. Goldberg Young Investigator Award. In addition to her research, she is committed to teaching and mentoring at Harvard Medical School.
At the Health Data Forum Global Summit, Dr. Shirley Wang will deliver a keynote address on "Real World Evidence for the Real World." Her presentation will explore the latest advancements in RWE methodologies, their practical applications in healthcare, and the future directions of health data science. Attendees will gain invaluable insights into harnessing RWE to drive meaningful improvements in patient care and health outcomes, making her keynote an essential highlight of the summit.
Elisa Tarazona Ginés, MD
Elisa Tarazona, a specialist in Family and Community Medicine, has extensive experience in healthcare management, including roles at La Fe Health Department in Valencia and La Ribera Health Department in Alzira, where she developed renowned integrated care models. With over 15 years of medical practice and a tenure as CEO of Ribera since 2020, Elisa has a strong background in healthcare operations, teaching, and research, with numerous scientific publications.
Elisa holds a Doctorate in Medicine from the University of Valencia, a Master's in Home Hospitalization from the Valencian School of Health Studies (EVES), and her contributions to the field are recognized in various national and international forums, reflecting her commitment to advancing healthcare practices.
As a guest keynote speaker, Elisa will bring a perspective from the health provider angle on the benefits of science in guiding hospital clinical decisions and improving patient care. Her insights will underscore the importance of evidence-based practices in enhancing healthcare outcomes and efficiency.
Dr. Saleem Sayani
Dr. Saleem Sayani is the Director of the Technology Innovation Support Center at Aga Khan University, where he leads various initiatives in health informatics and digital health. With a rich background in healthcare management and technology, Dr. Sayani has spearheaded numerous projects aimed at improving healthcare delivery through innovative technological solutions. He holds advanced degrees in health informatics and has extensive experience working with both academic and healthcare institutions globally. Dr. Sayani's leadership and expertise have been instrumental in advancing the integration of digital health solutions in healthcare systems, earning him recognition as a thought leader in the field. More information about his work can be found at Aga Khan University.
At the Health Data Forum Global Summit, Dr. Saleem Sayani will present a keynote on "Real World Evidence for the Real World." His address will cover the latest trends and advancements in digital health, the practical applications of RWE in improving healthcare delivery, and the future landscape of health informatics. Attendees will benefit from Dr. Sayani's deep knowledge and experience, gaining insights into how digital health and RWE can be leveraged to enhance patient outcomes and healthcare efficiency.
Maria de Belém Roseira
Maria de Belém Roseira, a distinguished lawyer, jurist, and politician, graduated in Law from the University of Coimbra in 1972. With over three decades dedicated to Social Affairs and political activity, she has served as Minister of Health, Minister for Equality, and Member of Parliament. As President of the Parliamentary Health Committee, she championed pivotal initiatives such as the Parity Law and the Medically Assisted Procreation Law.
She has also chaired the Inquiry Commission on the nationalization of Banco Português de Negócios, served as President of the World Health Assembly of the WHO, and led the Socialist Party. Maria de Belém is actively involved in volunteering and serves on the boards of various non-profit organizations and academic institutions.
Her numerous accolades include the Grand Cross of the Order of Christ and a Doctor Honoris Causa title from the European University in 2022.
We are honoured to have Maria de Belém Roseira open the pre-summit event on "The Impact of Real-World Evidence (RWE) in Clinical Pathways" at Nova SBE.
Pedro Ramos
Pedro Ramos was born in the parish of São Martinho, Funchal, in 1960. He is a surgeon at Hospital Dr. Nélio Mendonça and has extensive experience in Emergency Medicine and Trauma. From 2009 to June 2016, he served as Director of the Emergency Department at Hospital Dr. Nélio Mendonça, and from June to December 2016, he held the position of Clinical Director of the Health Service of the Autonomous Region of Madeira (SESARAM). He also led the Madeira Clinical Simulation Center from 2012 to 2016, fostering training activities at regional, national, and international levels.
In academia, Pedro Ramos was a Guest Lecturer at the University of Madeira from 2004 to 2016. He held leadership roles as the Coordinator of the Trauma Chapter of the Portuguese Society of Surgery and Vice-Chair of the Military and Disaster Section of the European Society for Trauma and Emergency Surgery. Additionally, he is an international instructor in several training programs, including TEAM, ATLS, DSTC, MRMI, and ETC.
On December 29, 2016, he assumed the role of Regional Secretary of Health in the 12th Government of the Autonomous Region of Madeira. On October 15, 2019, he became Regional Secretary of Health and Civil Protection in the 13th Government, a position he continues to hold in the 14th Government as of October 17, 2023.
Rui Santos Ivo
Rui Santos Ivo holds a degree in Pharmaceutical Sciences from the University of Lisbon (1987) and is a specialist in Hospital Pharmacy (Ministry of Health, 1992) and Pharmaceutical Regulation (Portuguese Pharmaceutical Society, 1997). He has completed postgraduate training in Health Law (University of Lisbon, 1997), Pharmaceutical Medicine (University of Basel, 1999), Regulation (LSE, 1999), and Health Unit Management (Portuguese Catholic University, 2000).
He began his career as a hospital pharmacist at Egas Moniz Hospital in Lisbon and joined INFARMED in 1993, where he served as vice president (1994-2000) and president (2002-2005). He was also a director at the European Medicines Agency (EMA) and a member of its Management Board. Later, he worked for the European Commission and led APIFARMA from 2008 to 2011. Since 2014, he has been the president of the Central Administration of the Health System (ACSS).
Rui Santos Ivo has been awarded several distinctions, including the Almofariz Prize for "Personality of the Year 2004," the European Corresponding Membership of the Académie de Pharmacie (France), and the Distinguished Service Medal – Gold Grade from the Portuguese Minister of Health in 2015.
Eric Sutherland
Eric is a Senior Health Economist leading the OECD’s work in Digital Health, bringing together policy guidance for digital tools, integrated data, and responsible analytics including artificial intelligence. In that role, he is accountable for measuring and evolving the OECD’s Recommendation on Health Data Governance (2017) and supporting digital health policy that provides data protection (e.g. security and privacy) and timely access to quality data to optimize the use of data for information, insights, and impact among individuals, health workers, policy makers, researchers, and innovators.
Before joining the OECD, Eric led the Secretariat for a pan-Canadian Health Data Strategy, bringing together experts and governmental leaders from across Canada to establish an integrated health data ecosystem that better uses data for health systems, public health, population health, research, and care. Eric authored the Pan-Canadian Health Data and Information Governance Framework and Toolkit and has taught courses in data science, health data governance, and privacy.
Elena Petelos
Elena Petelos is a Senior Research Fellow in Public Health and Lecturer in Evidence-Based Medicine at the University of Crete (Greece) and Maastricht University (Netherlands). With a background in molecular oncology and health economics, she also teaches at Charité-Universitätsmedizin Berlin and the University of West Attica (Greece).
Elena serves as the Vice President of the Health Technology Assessment (HTA) section at the European Public Health Association (EUPHA). She is also the Co-Chair of the Real-World Evidence (RWE) and Artificial Intelligence Interest Group at HTAi. Additionally, she holds key roles in various international health bodies, including advisory groups such as the Healthcare Professional’s Working Party of the European Medicines Agency (EMA) and the Advisory Forum of HERA at the European Commission. Her research and advocacy focus on international collaboration, real-world evidence, benefit/risk communication, and the integration of new technologies in healthcare, aiming for digital equity and improved global health outcomes.
Location: NOVA School of Business and Economics & NOVA Medical School
Our pre-summit Symposium is powered by UpHill Health
Location: Paula Rego Museum, Cascais
Location: Paula Rego Museum, Cascais
The Health Data Forum Global Hybrid Summit is returning in 2025, and we are inviting partners to help shape this landmark event in healthcare data. This year, we’re seeking innovative venue proposals to host the next edition of our summit, bringing together leaders, innovators, and changemakers dedicated to advancing healthcare through data-driven solutions.
Connect with key decision-makers and forge valuable partnerships that fuel progress.
Tailored sponsorship packages are available to meet your specific goals and budget.
Increase brand awareness and generate qualified leads through targeted exposure to a highly engaged audience.
If your organization or venue is interested in partnering with us to create an inspiring and impactful event,
reach out with your proposals. Together, let’s design an exceptional 2025 summit that advances healthcare through the power of data.
The "Data First, AI Later" movement is a global initiative committed to transforming healthcare by placing data integrity at the forefront of AI-driven innovation. Launched in collaboration with thought leaders and healthcare experts, this movement advocates for the responsible use of high-quality data as the foundation for effective and ethical AI applications.
By emphasizing transparency, accountability, and patient-centric values, we aim to ensure that AI in healthcare not only advances technology but also improves patient outcomes and fosters trust across the healthcare ecosystem. Join us at the Health Data Forum Summit in Cascais as we explore this transformative approach and its impact on the future of healthcare.
In the rush to adopt AI in healthcare, the critical role of data quality is often overlooked, leading to risks of biased algorithms, inaccurate predictions, and potential harm to patients. The "Data First, AI Later" movement was born out of the urgent need to prioritize data integrity as the foundation for any AI initiative. By ensuring that the data used is accurate, secure, and unbiased, we can unlock the true potential of AI to improve patient outcomes and build a more ethical, effective, and trustworthy healthcare system. AI should come later—only after we have established a robust and reliable data foundation.
This Declaration, curated by the i-HD (The European Institute for Innovation through Health Data) is the outcome of the Health Data Quality: a Dynamic Complexity summit event held in Porto's Faculty of Medicine - University of Porto - on 17 & 18 November 2022. The first international conference ever held on the topic of health data quality. The conference’s objective was to demonstrate the dynamic complexity of high-quality data, as well as for primary and secondary use. The Porto declaration is the result of an interactive conference with over 400 experts, representing multiple -public and industry stakeholders, including key policy-making bodies such as the European Commission, the WHO and a number of national governments.
Develop and promote data quality standards and labelling
1. Decision makers and data scientists must work together - urgently - on a European standard for data quality labelling for primary and secondary data use, including provenance and FAIR reuse metadata.
2. Multiple healthcare and research funders must be prepared to co-finance the development of these data quality standards, their adoption into labels and products and the upgrade of deployed systems to ensure standardised high-quality, high-value data for all.
Develop and certify digital health products to have data quality by design.
3. ICT companies, especially EHR system developers, must build in “data quality by design” so that users find it easy to enter high-quality data and can tell the quality of the data they access and use.
4. ICT companies, especially EHR system developers, must value the quality, reliability, and trustworthiness of the health data their systems create and process, and certify their products against these criteria.
Require data quality labels within all digital health and research products
5. Member States and the European Commission must align their evidence requirements, including data quality requirements, for the approval of digital health innovations within European health systems.
6. Purchasers of digital health products and platforms, including EHR systems, must prioritize the adoption of systems that facilitate and label high-quality health data.
Invest in education and organizational change to improve data quality
7. Health and Finance ministries, health insurers and the data-using industry sectors must align their KPIs to join forces to invest in high-quality data in health-related activity. Furthermore, all stakeholders involved should engage in educating and empowering patients (and patient organizations) and the public to capture their own data to a high quality and to encourage its use for purposes they support.
8. Secondary use stakeholders must urgently support healthcare organizations with the uptake of education and the organizational changes needed to improve data quality.
Develop the multi-stakeholder business case for high-quality data
9. Member States and the European Commission must develop and promote business cases for investment to improve health data quality.
10. Member States and the European Commission must establish co-financing frameworks to share out the necessary investments amongst the data user stakeholders
Edited by Jens Declerk, Conference Program Manager, i-HD The European Institute for Innovation through Health Data
Delve into the archives of the Health Data Forum Global Hybrid Summits since 2019. Explore past editions and gain valuable insights into the evolution of healthcare data. These retrospectives offer a sober and informative look at the progress, challenges, and innovations that have shaped the healthcare landscape. Join us in understanding the pivotal moments that have brought us to where we are today in the world of health data.
Thanks to the generous support of the Municipality of Cascais, last year's Health Data Forum Global Hybrid Summit was hosted at the stunning auditorium of the Paulo Rego Museum in Cascais.
This unique and precious venue, known for its architectural beauty and cultural significance, provides an inspiring setting for exploring the future of healthcare data. It reflects our commitment to fostering collaboration and innovation in healthcare within a vibrant and historical environment.
We’re gearing up for the Health Data Forum 2025, where cutting-edge discussions on Real-World Evidence (RWE), Health Data Governance, Medical Devices, Wearables, and Chronic Disease Management will take center stage.
🔹
Stay Ahead: Be the first to receive updates on speakers, schedules, and exclusive content.
🔹
Secure Your Spot: Pre-register now to ensure your place at the next big healthcare data innovation event.
The Health Data Forum Ltd is UK Charity dedicated to healthcare data thought leadership.
Kemp House 160 City Road, London EC1V 2NX
We strictly adhere to GDPR regulations, ensuring your data is securely stored. You can exercise your data privacy rights at any time with confidence. See our privacy policy
here.